Limitations and opportunities in breath research in the face of the COVID-19 pandemic

Sawano, Makoto; Beauchamp, Jonathan

doi:10.1088/1752-7163/ac9db5

Cited by 1 publication

(1 citation statement)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Globally, as of today, there have been over 770 million confirmed cases of COVID-19, including nearly 7 million deaths [17]. Research towards screening platforms for COVID-19 infections has been emphasized to provide more sensitive, specific, and reliable tests that are non-invasive and can be accessible to the entire population-of which the suitability of breath analysis has been previously evaluated in detail [18]. At the Breath Biopsy Conference 2023, Dr Lorena Diaz de Leon Martinez presented the poster 'SARS CoV-2 Infection Screening via the Exhaled Breath Fingerprint Obtained by FTIR Spectroscopic Gas Phase Analysis' .…”

Section: Microbial Metabolism Is a Major Producer Of The Vocs In Exha...mentioning

confidence: 99%

Establishing breath as a biomarker platform—take home messages from the Breath Biopsy Conference 2023

Chou,

Godbeer,

Ball

2024

J. Breath Res.

View full text Add to dashboard Cite

The annual Breath Biopsy Conference hosted by Owlstone Medical gathers together the leading experts, early career researchers, and physicians working with breath as a biomarker platform for clinical purposes. The current topics in breath research are discussed and presented, and an overarching topical theme is identified and discussed as part of an expert panel to close the conference. The profiling of normal breath composition and the establishment of standards for analyzing breath compared to background signal were two important topics that were major focuses of this conference, as well as important innovative progress that has been made since last year, including the development of a non-invasive breath test for lung cancer and liver disease. This meeting report offers an overview of the key take-home messages from the various presentations, posters, and discussions from the conference.

show abstract

Section: Microbial Metabolism Is a Major Producer Of The Vocs In Exha...mentioning

confidence: 99%

Establishing breath as a biomarker platform—take home messages from the Breath Biopsy Conference 2023

Chou,

Godbeer,

Ball

2024

J. Breath Res.

View full text Add to dashboard Cite

show abstract

Limitations and opportunities in breath research in the face of the COVID-19 pandemic

Abstract: N/A (editorial)

Cited by 1 publication

References 24 publications

Establishing breath as a biomarker platform—take home messages from the Breath Biopsy Conference 2023

Establishing breath as a biomarker platform—take home messages from the Breath Biopsy Conference 2023

Contact Info

Product

Resources

About